Cognitive Flexibility Deficits in Early Recovery from Methamphetamine Use Resemble Parkinsonian Phenotype

Overview

This study demonstrates that individuals recently abstinent from methamphetamine exhibit cognitive inflexibility similar to early Parkinson’s disease (PD), as measured by the Trail Making Test (TMT). Notably, intravenous methamphetamine use in females is associated with greater cognitive deficits, suggesting sex-specific vulnerability.

Background

Methamphetamine misuse is linked to increased risk of Parkinson’s disease, likely due to dopaminergic neurotoxicity affecting fronto-striatal circuits. Both conditions impair executive functions, particularly cognitive flexibility, which can be assessed using the Trail Making Test. While animal and post-mortem studies have shown overlapping pathology, clinical evidence of a Parkinsonian-like cognitive phenotype in methamphetamine users has been limited. Understanding these deficits is critical as they may hinder treatment engagement and recovery.

Data Highlights

Key Findings

• Individuals with MUD showed significant cognitive inflexibility on the Trail Making Test compared to controls, consistent with early PD deficits.
• Age of first methamphetamine use, duration, and total amount used did not significantly affect cognitive performance.
• Intravenous methamphetamine use was associated with increased TMT errors in females but not males, indicating sex-specific vulnerability.
• The observed cognitive deficits reflect fronto-striatal dysfunction similar to that seen in prodromal Parkinson’s disease.
• This study is among the first to clinically demonstrate a Parkinsonian-like cognitive phenotype in humans with MUD.

Clinical Implications

Clinicians should be aware that cognitive inflexibility resembling early Parkinsonian symptoms may be present in patients recovering from methamphetamine use, particularly in females who inject the drug. These executive function deficits could impair treatment adherence and relapse prevention, underscoring the need for tailored cognitive interventions. Screening for such impairments may improve comprehensive care strategies in methamphetamine use disorder.

Conclusion

The findings support a model in which methamphetamine use induces Parkinsonian-like cognitive deficits, especially in cognitive flexibility, prior to motor symptoms. Recognizing this phenotype may enhance understanding of methamphetamine’s neurotoxic effects and inform targeted treatment approaches.

References

1. Author/Source/2024 -- Cognitive Assessment in Early Recovery from Methamphetamine Use: Evidence of a Parkinsonian-like Phenotype in Humans